Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1996-07-31
1999-08-31
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 7801, 424428, 424488, 424497, 435455, 4353201, 435325, A01N 6300
Patent
active
059451009
ABSTRACT:
The major problem with current direct delivery techniques of therapeutic reagents into solid tumors, especially of cells or large volumes of recombinant DNA reagents or drugs, has been resistance of the tissues to the influx of the fluid and/or cells, resulting in low quantities of the fluid and/or cells penetrating into and remaining in the tumor tissue to be treated. Increased penetration and/or reduced backflow and diversion through the point of entry, so that more material is introduced into and remains in the tumor, is obtained through the use of a viscous vehicle, most preferably having a similar density to tissue, for the material to be delivered. Preferred materials include solutions or suspensions of a polymeric material which gel or solidify at the time of or shortly after injection or implantation. In the preferred embodiment, the solution is injected via a catheter into regions of the tumor to be treated.
REFERENCES:
patent: 4352883 (1982-10-01), Lim
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5441732 (1995-08-01), Hoeg et al.
patent: 5552309 (1996-09-01), March
patent: 5599534 (1997-02-01), Himmelstein et al.
patent: 5652225 (1997-07-01), Isner
patent: 5656481 (1997-08-01), Baetge et al.
patent: 5770580 (1998-06-01), Ledley et al.
Ledley (1995) Hum. Gene Ther. 6:1129-44
Ronald Crystal (1995) Science, vol. 270:404-409
Coglan (Nov. 1995) New Scientist, pp. 14-15.
Park (1993) Adv. Drug Del. Rev. 11:59-84.
Kuo et al. (1996) Crit. Rev. Eukar. Gene Expression, 6(1):68.
Jain (1994) Scientific America, 271(1):58-63.
Monsigny et al. (1995) Adv. Drug Delivery Rev. 14:1-24.
Petrak (1993) Particulate Carrier, Ronald Allan (1993), pp. 275-293.
Gunzburg et al., vol. 1, No. 9, pp. 410-417, 1995.
Mastrangelo et al. (Seminars in Oncology, 1996, vol. 23, 1:4-21).
Colombo, et al., "The `Bystander Effect`: Association of U-87 Cell Death with Ganciclovir-Mediated Apoptosis of Nearby Cells and Lack of Effect in Athymic Mice," Human Gene Therapy 6:763-772 (1992).
Fick, et al., "The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro," Proc. Natl. Acad. Sci. USA 92:11071-11075 (1995).
Alkan-Onyuksel, et al., "A Mixed Micellar Formulation Suitable for the Parental Administration of Taxol" Pharm. REs. 11(2), 206-212 (1994).
Bagshawe, K.D., "Towards generating cytotoxic agents at cancer sites" Br. J. Cancer, 60:275-281, (1989).
Bagshawe, et al., "A cytotoxic agent can be generated selectively at cancer sites" Br. J. Cancer, 58:700-703 (1988).
Balzarini, et al., "Differential Mechanism of Cytostatic Effect of (E)-5-(2-Bromovinyl)-2'-deoxyuridine, 9-(1,3-Dihydroxy-2-propoxymethyl)guanine, and Other Antiherpetic Drugs on Tumor Cells Transfected by the Thymidine Kinase Gene of Herpes Simplex Virus Type 1 or Type 2" J. Biol. Chem., 268:6332-6337 (1993).
Battelli, et al., "T lymphocyte killing by a xanthine-oxidase-containing immunotoxin" Cancer Immunol. Immunother., 35:421-425 (1992).
Berkner et al., 1987 "Abundant Expression of Polyomavirus Middle T Antigen and Dihydrofolate Reductase in an Adenovirus Recombinant" J. Virology 61:1213-1220 (1987).
Bout, "Lung Gene Therapy: In Vivo Adenovirus-Mediated Gene Transfer to Rhesus Monkey Airway Epithelium" Human Gene Therapy 5:3-10 (1994).
Brem et al., "Intraoperative Chemotherapy using biodegradable polymers: Safety and Effectiveness for Recurrent Glioma Evaluated by a Prospective, Multi-Institutional Placebo-Controlled Clinical Trial" Proc. Amer. Soc. Clin. Oncology (May 17, 1994).
Brem, et al., Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas J. Neurosurg. 74:441-446 (1991).
*Brem, et al., "Polymers as Controlled Drug Delivery Devices for the Treatment of Malignant Brain Tumors" Eur. J. Pharm. Biopharm. 39(1):2-7 (1993).
Brown and Burlingham, "Penetration of Host Cell Membranes by Adenovirus 2" J. Virology 12:386-396 (1973).
*Brown and Greene, DNA and Cell Biology 10(6):399-409 (1991).
Bruce and Meeker, "Comparison of the Sensitivity of Hematopoietic Colony-Forming Cells in Different Proliferative States to 5-Fluorouracil" J. Natl. Cancer Inst., 38:401-405 (1967).
Caillaud et al., "Adenoviral Vector as a Gene Delivery System into Cultured Rat Neuronal and Glial Cells" Eur. J. Neuroscience 5:1287-1291 (1993).
Chardonnet and Dales, "Early Events in the Interaction of Adenoviruses with HeLa cells: I. Penetration of Type 5 and Intracellular Release of the DNA Genome" Virology 40:462-477 (1970).
Concise Encyclopedia of Polymer Science and Polymeric Amines and Ammonium Slats, E. Goethals, editor (Pergamon Press, Elmsford, NY 1980).
Culver, et al., "In Vivo Gene Transfer with Retroviral Vector-Produced Cells for Treatment of Experimental Brain Tumors" Science 256:1550-1552 (1992).
Davidson et al., "Overproduction of Polyomavirus Middle T Antigen in Mammalian Cells through the Use of an Adenovirus Vector" J. Virology 61:1226-1239 (1987).
Gomez-Foix, "Adenovirus-mediated Transfer of the Muscle Glycogen Phosphorylase Gene into Hepatocytes Confers Altered Regulation of Glycogen Metabolism" J. Biol. Chem. 267:25129-25134 (1992).
Gottlieb, J.A., and J.K. Luce, "Treatment of Malignant Melanoma with Camptothecin" Cancer Chemother. Rep. 56(1):103-105 (1972).
Guzman, "Efficient Gene Transfer Into Myocardium by Direct Injection of Adenovirus Vectors" Circulation Research 73:1201-1207 (1993)
Haj-Ahmad et al,. "Development of a Helper-Independent Human Adenovirus Vector and Its Use in the Transfer of the Herpes Simplex Virus Thymidine Kinase Gene" J. Virology 57:267-274 (1986).
Harrison's Principles of Internal Medicine 431-446, E. Braunwald, et al., ed., McGraw-Hill Book Co. (1987).
Hughes et al., "Monoclonal Antibody Targeting of Liposomes to Mouse Lung in Vivo" Cancer Research, 49:6214-6220, (1989).
Kirshenbaum, J. Clin. Invest. 92:381-387 (1993).
La Salle, "An Adenovirus Vector for Gene Transfer into Neurons and Glia in the Brain" Science 259:988-900 (1993).
Langer, R., and D. Wise, eds, Medical Applications of Controlled Release, vol. I and II, Boca Raton, CRC Press (1986).
Litzinger and Huang, "Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes" Biochmimica et Biophysica Acta, 1104:179-187, 1992).
Massie et al., "Construction of a Helper-Free Recombinant Adenovirus That Expresses Poluomavirus Large T Antigen" Mol. Cell. Biol. 6:2872-2883 (1986).
* Matsuda et al., AsAID Trans., 38:154-157 (1992).
Moertel, C.G., et al., "Phase II Study of Camptothecin (NSC-100880) in the Treatment of Advanced Gastrointestinal Cancer" Cancer Chemother. Rep. 56(1):95-101 (1972).
Morsy, "Efficient Adenoviral-mediated Ornithine Transcarbamylase Expression in Deficient Mouse and Human Hepatocytes" J. Clin. Invest. 92:1580-1586 (1993).
Mouller, "Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts" Nature Genetics 4:154-159 (1993).
Muggia, F.M., et al., "Phase I Clinical Trial of Weekly and Daily Treatment with Camptothecin (NSC-100880): Correlation With Preclinical Studies" Cancer Chemother. Rep. 56(4):515-521 (1972).
Mullen, C.A., "Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system" Proc. Natl. Acad. Sci. 89:33-37 (1992).
Mulligan, "The Basic Science of Gene Therapy" Science 260:926-932 (1993).
Petrie, C.R., et al., "A Novel Biotinylated Adenylate Analogue Derived from 2:441-446 (1991).
Pietersaz and McKnezie, "Antibody Conjugates for the Treatment of Cancer" Immunolog. Reviews, 129:57-80, (1992).
Ragot, T., et al,. "Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin" J. Gen. Virology 74:501-507 (1993).
Ram et al., "In Situ Retroviral-mediated Gene Transfer for the Treatment of Brain Tumors in Rats" Cancel Res., 53:83-88 (1993).
Rich, "Development and
Campell Bruce R.
FBP Corporation
Nguyen Dave Trong
LandOfFree
Tumor delivery vehicles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor delivery vehicles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor delivery vehicles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2425922